BioSpace News Archive

Aceto, a leading global provider of specialty materials for life sciences and advanced technology end markets, announced today its acquisition of A&C, a global GMP (Good Manufacturing Practices) manufacturer of specialty excipients, buffers, and process solutions.

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced that the European Medicines Agency has started a review of VIR-7831, an investigational dual-action SARS-CoV-2 monoclonal antibody, for the treatment of adults and adolescents with COVID-19 who do not require oxygen supplementation and who are at high risk of progressing to severe COVID-19.

HepaTx Corporation, a preclinical stage company developing cell therapies for the treatment of liver disease, is pleased to announce the appointment of Salah Kivlighn, PhD as Chief Executive Office.

“Utilization of a Novel Negative Pressure Platform Wound Dressing on Surgical Incisions: A Case Series”

As Canadians remain impacted by the spread of COVID-19, Apotex, Canada’s largest pharmaceutical company has been awarded a contract with the Government of Canada to supply the Critical Drug Reserve of Dexamethasone tablets in response to the COVID-19 pandemic.

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced that the company plans to issue a pre-market press release and conduct a webcast on Friday, April 16, 2021, to discuss clinical data from the ongoing Phase 1/2 trial evaluating darovasertib

Agilent Technologies, Inc. (NYSE: A) today announced it has completed the acquisition of Resolution Bioscience, a leader in the development and commercialization of next-generation sequencing (NGS)-based precision oncology solutions.

BirchBioMed Inc., a clinical-stage immunology company focused on the prevention and reduction of immunological fibrotic conditions and defects in the immune system, is pleased to announce the appointment of translational biophysicist and inventor Jonathan W. Bourne, Ph.D. as its new Chief Science Officer.

Dow has declared a dividend of 70 cents per share, payable June 11, 2021, to shareholders of record on May 28, 2021.

The clinic opened in March and offers a comfortable and convenient location for ScreenPro clients.